Concourse Financial Group Securities’s Tandem Diabetes Care TNDM Stock Holding History

Concourse Financial Group Securities’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1	Closed	-$35	–	1872
2024 Q4	$35	Hold	1	–	–	﹤0.01%	2232
2024 Q3	$42	Hold	1	–	–	﹤0.01%	2224
2024 Q2	$40	Hold	1	–	–	﹤0.01%	2281
2024 Q1	$35	Hold	1	–	–	﹤0.01%	2288
2023 Q4	$29	Hold	1	–	–	﹤0.01%	2262
2023 Q3	$20	Buy	+1	New	+$27	﹤0.01%	2291
2023 Q1	–	Sell	-398	Closed	-$16.5K	–	2436
2022 Q4	$17.9K	Buy	398 +99	+33%	+$4.48K	﹤0.01%	1503
2022 Q3	$14K	Buy	299 +35	+13%	+$1.92K	﹤0.01%	1401
2022 Q2	$16K	Buy	+264	New	+$21.7K	﹤0.01%	1522
2020 Q2	–	Sell	-396	Closed	-$31.6K	–	2254
2020 Q1	$25K	Hold	396	–	–	﹤0.01%	1163
2019 Q4	$24K	Buy	+396	New	+$24.4K	﹤0.01%	1207
2019 Q3	–	Sell	-467	Closed	-$29.8K	–	2130
2019 Q2	$30K	Buy	467 +396	+558%	+$25.6K	﹤0.01%	1066
2019 Q1	$4K	Buy	+71	New	+$3.73K	﹤0.01%	1855

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Concourse Financial Group Securities's TNDM Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 1 share — an estimated $35 sold.

Concourse Financial Group Securities first reported a position in TNDM in Q1 2019 and held it in 13 quarters. The position peaked at $30K in Q2 2019. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

Concourse Financial Group Securities reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
Concourse Financial Group Securities sold 1 Tandem Diabetes Care share in Q1 2025, an estimated $35.
Concourse Financial Group Securities first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 13 quarters.
Concourse Financial Group Securities's Tandem Diabetes Care position peaked at $30K in Q2 2019.
275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.